Lavaca Capital LLC Abb Vie Inc. Put Options Transaction History

Lavaca Capital LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2022 Aug 12, 2022	SELL	$137.62 - $174.96 $96,334 - $122,472	-700 Reduced 7.53%	8,600 $1.32 Million
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $26,395 - $32,750	-200 Reduced 2.11%	9,300 $1.51 Million
Q4 2021 Feb 10, 2022	SELL	$107.43 - $135.93 $32,229 - $40,779	-300 Reduced 3.06%	9,500 $1.29 Million
Q2 2021 Aug 13, 2021	BUY	$105.21 - $117.21 $1.03 Million - $1.15 Million	9,800 New	9,800 $1.1 Million

3,852

1.25B

16.8M

12.2M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Lavaca Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Lavaca Capital LLC with notifications on news.